Karyopharm Therapeutics Inc. (KPTI): Price and Financial Metrics
KPTI Price/Volume Stats
| Current price | $0.78 | 52-week high | $1.95 |
| Prev. close | $0.77 | 52-week low | $0.62 |
| Day low | $0.76 | Volume | 367,400 |
| Day high | $0.79 | Avg. volume | 1,243,215 |
| 50-day MA | $0.83 | Dividend yield | N/A |
| 200-day MA | $1.02 | Market Cap | 97.12M |
KPTI Stock Price Chart Interactive Chart >
Karyopharm Therapeutics Inc. (KPTI) Company Bio
Karyopharm Therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. The company was founded in 2008 and is based in in Newton, Massachusetts.
KPTI Price Returns
| 1-mo | -8.33% |
| 3-mo | -6.42% |
| 6-mo | -25.71% |
| 1-year | 9.77% |
| 3-year | -89.67% |
| 5-year | -95.21% |
| YTD | -9.83% |
| 2023 | -74.56% |
| 2022 | -47.12% |
| 2021 | -58.46% |
| 2020 | -19.25% |
| 2019 | 104.59% |
Continue Researching KPTI
Want to see what other sources are saying about Karyopharm Therapeutics Inc's financials and stock price? Try the links below:Karyopharm Therapeutics Inc (KPTI) Stock Price | Nasdaq
Karyopharm Therapeutics Inc (KPTI) Stock Quote, History and News - Yahoo Finance
Karyopharm Therapeutics Inc (KPTI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...